BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 09, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Pixuvri pixantrone regulatory update

Cell Therapeutics said it reached an agreement with Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband) on the price for Pixuvri pixantrone to treat multiply relapsed or refractory aggressive non-Hodgkin's B cell lymphoma. The company declined to disclose the price, but...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >